Embla Medical hfOSSFF 92 Cash Ratio is 0.25 as of Mar. 2026, which is 34% below its 10-year median of 0.38. GuruFocus rates OSSFF with a GF Score™ of 92/100 and a GF Value™ of $5.33. The stock has 2 warning signs investors should review. Among 843 Medical Devices & Instruments companies, Embla Medical hf ranks worse than 81.85% on this metric.
Embla Medical hf has a Cash Ratio of 0.25. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for Embla Medical hf's Cash Ratio or its related term are showing as below:
OSSFF'
s Cash Ratio Range Over the Past 10 Years
Min: 0.19 Med: 0.38 Max: 1
Current: 0.25
During the past 13 years, Embla Medical hf's highest Cash Ratio was 1.00. The lowest was 0.19. And the median was 0.38.
OSSFF's Cash Ratio is ranked worse than 81.85% of 843
companies
in the Medical Devices & Instruments industry
Industry Median: 0.97
vs OSSFF: 0.25
Embla Medical hf (OTCPK:OSSFF) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Embla Medical hf Cash Ratio Related Terms
Embla Medical hf Cash Ratio Historical Data
* Premium members only.
The historical data trend for Embla Medical hf's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Embla Medical hf's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embla Medical hf Cash Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Embla Medical hf's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Embla Medical hf (OSSFF) has a Cash Ratio of 0.25 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Embla Medical hf and its competitors. This is 34% below median its historical median of 0.38. Over the past decade, Embla Medical hf's Cash Ratio has ranged from 0.19 to 1.00. According to the industry distribution chart, Embla Medical hf ranks #690 out of 843 companies in the Medical Devices & Instruments industry, placing it in the top 81.9%.
Is Embla Medical hf's Cash Ratio too high?
Embla Medical hf's current Cash Ratio of 0.25 is 34% below median its 10-year median of 0.38. Over the past 10 years, this metric has ranged from a low of 0.19 to a high of 1.00. The Medical Devices & Instruments industry median Cash Ratio is 0.97. Embla Medical hf's value of 0.25 is 74.2% below this industry median. Based on the distribution chart, Embla Medical hf ranks #690 out of 843 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Embla Medical hf has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's Cash Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Embla Medical hf ranks #690 out of 843 companies for Cash Ratio. This places Embla Medical hf in the lower half of its industry. The industry median Cash Ratio is 0.97. Embla Medical hf's value of 0.25 is 74.2% below this benchmark. Historically, Embla Medical hf's own Cash Ratio has ranged from 0.19 to 1.00 over the past decade. While the company's 10-year median is 0.38 vs. the industry median of 0.97, Embla Medical hf has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Medical Devices & Instruments company?
The median Cash Ratio among Medical Devices & Instruments companies is 0.97, based on 843 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Embla Medical hf's current Cash Ratio of 0.25 is 74.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Embla Medical hf and its competitors. For the Medical Devices & Instruments industry, the median Cash Ratio is 0.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Embla Medical hf's current Cash Ratio is 0.25, which is 34% below median its own 10-year median of 0.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Embla Medical hf (OSSFF) has a current Cash Ratio of 0.25. The stock's GF Value™ is $5.33, compared to a current price of $4.15 — trading 22.1% below its estimated fair value. The current Cash Ratio is 0.25, which is 34% below median its 10-year median of 0.38 and 74.2% below the Medical Devices & Instruments industry median of 0.97. Embla Medical hf's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Embla Medical hf (OSSFF), the current Cash Ratio is 0.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Embla Medical hf (OSSFF) Overvalued in 2026?
Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued.
The current stock price of $4.15 is trading 22.1% below its estimated GF Value™ of $5.33.
Key valuation signals for OSSFF:
Cash Ratio: 0.25 (34% below median its 10-year median of 0.38)
GF Value™: $5.33 vs. price of $4.15 (22.1% below fair value)
Industry Position: 74.2% below the Medical Devices & Instruments median (#690 of 843)
No single metric tells the full story. See the OSSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
92GF Score
Get the complete analysis for OSSFF
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSSFF has been successfully added to your 
